Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-03

FDA Approved: LACOSAMIDE — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved Fresenius Kabi USA, LLC's original application for lacosamide (ANDA214677), allowing the marketing of a generic lacosamide product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

ORIG AP for LACOSAMIDE (LACOSAMIDE)